Neovascular glaucoma: A retrospective analysis of treatment with peripheral panretinal cryotherapy

L. P. Brodell; R. J. Olk; N. P. Arribas; E. Okun; G. P. Johnston; I. Boniuk; R. F. Escoffery; M. G. Grand; D. B. Burgess; L. H. Schoch

Neovascular glaucoma: A retrospective analysis of treatment with peripheral panretinal cryotherapy

L. P. Brodell, R. J. Olk, N. P. Arribas, E. Okun, G. P. Johnston, I. Boniuk, R. F. Escoffery, M. G. Grand, D. B. Burgess, L. H. Schoch

Department of Ophthalmology and Visual Sciences

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

A retrospective analysis of thirty-one eyes in thirty patients with neovascular glaucoma (NVG) associated with proliferative diabetic retinopathy or venous occlusive disease was performed. Eyes treated with transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy had improvement or stabilization of visual acuity in 55%, reduction of intraocular pressure in 55%, and stabilization or regression of iris neovascularization in 70% of eyes at 12-14 months post-treatment. Transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy is recommended in the treatment of eyes with NVG and media opacities precluding photocoagulation therapy, or in eyes unresponsive to previous photocoagulation therapy.

Original language	English
Pages (from-to)	200-206
Number of pages	7
Journal	Ophthalmic Surgery
Volume	18
Issue number	4
State	Published - Aug 17 1987

Cite this

@article{bfd3b22d4110401d884da8cbc3922dee,

title = "Neovascular glaucoma: A retrospective analysis of treatment with peripheral panretinal cryotherapy",

abstract = "A retrospective analysis of thirty-one eyes in thirty patients with neovascular glaucoma (NVG) associated with proliferative diabetic retinopathy or venous occlusive disease was performed. Eyes treated with transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy had improvement or stabilization of visual acuity in 55%, reduction of intraocular pressure in 55%, and stabilization or regression of iris neovascularization in 70% of eyes at 12-14 months post-treatment. Transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy is recommended in the treatment of eyes with NVG and media opacities precluding photocoagulation therapy, or in eyes unresponsive to previous photocoagulation therapy.",

author = "Brodell, {L. P.} and Olk, {R. J.} and Arribas, {N. P.} and E. Okun and Johnston, {G. P.} and I. Boniuk and Escoffery, {R. F.} and Grand, {M. G.} and Burgess, {D. B.} and Schoch, {L. H.}",

year = "1987",

month = aug,

day = "17",

language = "English",

volume = "18",

pages = "200--206",

journal = "Ophthalmic Surgery",

issn = "0022-023X",

number = "4",

}

TY - JOUR

T1 - Neovascular glaucoma

T2 - A retrospective analysis of treatment with peripheral panretinal cryotherapy

AU - Brodell, L. P.

AU - Olk, R. J.

AU - Arribas, N. P.

AU - Okun, E.

AU - Johnston, G. P.

AU - Boniuk, I.

AU - Escoffery, R. F.

AU - Grand, M. G.

AU - Burgess, D. B.

AU - Schoch, L. H.

PY - 1987/8/17

Y1 - 1987/8/17

N2 - A retrospective analysis of thirty-one eyes in thirty patients with neovascular glaucoma (NVG) associated with proliferative diabetic retinopathy or venous occlusive disease was performed. Eyes treated with transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy had improvement or stabilization of visual acuity in 55%, reduction of intraocular pressure in 55%, and stabilization or regression of iris neovascularization in 70% of eyes at 12-14 months post-treatment. Transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy is recommended in the treatment of eyes with NVG and media opacities precluding photocoagulation therapy, or in eyes unresponsive to previous photocoagulation therapy.

AB - A retrospective analysis of thirty-one eyes in thirty patients with neovascular glaucoma (NVG) associated with proliferative diabetic retinopathy or venous occlusive disease was performed. Eyes treated with transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy had improvement or stabilization of visual acuity in 55%, reduction of intraocular pressure in 55%, and stabilization or regression of iris neovascularization in 70% of eyes at 12-14 months post-treatment. Transconjunctival peripheral panretinal cryotherapy alone, or in combination with limited cyclocryotherapy is recommended in the treatment of eyes with NVG and media opacities precluding photocoagulation therapy, or in eyes unresponsive to previous photocoagulation therapy.

UR - http://www.scopus.com/inward/record.url?scp=0023237634&partnerID=8YFLogxK

M3 - Article

C2 - 2438615

AN - SCOPUS:0023237634

SN - 0022-023X

VL - 18

SP - 200

EP - 206

JO - Ophthalmic Surgery

JF - Ophthalmic Surgery

IS - 4

ER -

Neovascular glaucoma: A retrospective analysis of treatment with peripheral panretinal cryotherapy

Abstract

Other files and links

Fingerprint

Cite this